Showing results (171-180 of 206) with videos related to
Sort By:
Pageof 21
Retrovirology|January 24, 2015
Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virusTinoush Moulaei, Kabamba B Alexandre, Shilpa R Shenoy, et al.Plos Biology|April 29, 2021
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodiesXing Zhu, Dhiraj Mannar, Shanti S Srivastava, et al.The Oncologist|August 25, 2017
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and BeyondLee Pai-Scherf, Gideon M Blumenthal, Hongshan Li, et al.Nature Communications|February 9, 2022
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variantsJames W Saville, Dhiraj Mannar, Xing Zhu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2017
FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic MelanomaAmy Barone, Maitreyee Hazarika, Marc R Theoret, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic SyndromesNina Kim, Kelly J Norsworthy, Sriram Subramaniam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid LeukemiaKelly J Norsworthy, Kunthel By, Sriram Subramaniam, et al.Plos Pathogens|January 5, 2011
Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structureTommi A White, Alberto Bartesaghi, Mario J Borgnia, et al.Iucrj|June 22, 2026
Cryo-EM-guided subtractive optimization of a novel VCP/p97 inhibitorJason Crawford, Ravi Munuganti, Charles Leung, et al.The AAPS Journal|January 1, 2015
Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidanceBrian Booth, Mark E Arnold, Binodh DeSilva, et al.Pageof 21